These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 22886419)

  • 1. Yes-associated protein regulates the hepatic response after bile duct ligation.
    Bai H; Zhang N; Xu Y; Chen Q; Khan M; Potter JJ; Nayar SK; Cornish T; Alpini G; Bronk S; Pan D; Anders RA
    Hepatology; 2012 Sep; 56(3):1097-107. PubMed ID: 22886419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yes-associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice.
    Xie J; Fan Y; Jia R; Yang F; Ma L; Li L
    J Pathol; 2021 Sep; 255(1):95-106. PubMed ID: 34156701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by
    Tharehalli U; Svinarenko M; Kraus JM; Kühlwein SD; Szekely R; Kiesle U; Scheffold A; Barth TFE; Kleger A; Schirmbeck R; Kestler HA; Seufferlein T; Oswald F; Katz SF; Lechel A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.
    Gurda GT; Zhu Q; Bai H; Pan D; Schwarz KB; Anders RA
    Hum Pathol; 2014 May; 45(5):1057-64. PubMed ID: 24746211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA6 modulates the ductular reaction to bile duct ligation.
    Pihlajoki M; Soini T; Cochran RB; Liljeström E; Huang J; Rudnick DA; Dietzen DJ; Kyrönlahti A; Pakarinen MP; Heikinheimo M; Wilson DB
    Hepatol Int; 2021 Feb; 15(1):166-178. PubMed ID: 33486744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis.
    Verboven E; Moya IM; Sansores-Garcia L; Xie J; Hillen H; Kowalczyk W; Vella G; Verhulst S; Castaldo SA; Algueró-Nadal A; Romanelli L; Mercader-Celma C; Souza NA; Soheily S; Van Huffel L; Van Brussel T; Lambrechts D; Roskams T; Lemaigre FP; Bergers G; van Grunsven LA; Halder G
    Gastroenterology; 2021 Feb; 160(3):847-862. PubMed ID: 33127392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury.
    Fenlon M; Short C; Xu J; Malkoff N; Mahdi E; Hough M; Glazier A; Lee C; Asahina K; Wang KS
    Physiol Rep; 2020 Jul; 8(14):e14508. PubMed ID: 32686913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
    Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
    Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.
    Liu R; Li X; Huang Z; Zhao D; Ganesh BS; Lai G; Pandak WM; Hylemon PB; Bajaj JS; Sanyal AJ; Zhou H
    Hepatology; 2018 Apr; 67(4):1441-1457. PubMed ID: 28926118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
    Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
    JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y; Seki E; Adachi M; Suetsugu A; Ito H; Moriwaki H; Seishima M; Nagaki M
    Hepatology; 2010 Jan; 51(1):237-45. PubMed ID: 19821528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.